Regiocit Solution for haemofiltration
Authorisation PA25288/008/001 · Vantive Belgium SRL
- Licence holder
- Vantive Belgium SRL (all products →)
- Active substances
- Sodium citrate, Sodium chloride
- Dosage form
- Solution for haemofiltration
- Route of administration
- Intravenous use
- ATC code
- B05ZB
- First authorised
- 14/11/2014
- Prescription status
- Product subject to prescription which may not be renewed (A)
- Supply
- Supply through pharmacies only
- Legal basis
- Well-established use application (Article 10a of Directive No 2001/83/EC)
Sodium citrate: supply and approvals
126 authorised products on the HPRA list contain Sodium citrate. Shortage records below are for the substance in the EU, US and German markets and may not affect this Irish product; for Irish supply, check with the HPRA or a pharmacist.
- EU shortage (EMA)
- No entry in the EMA shortage catalogue (checked 20 Nov 2026)
- US shortage (FDA)
- Sodium Acetate Injection: in shortage, updated 15 Nov 2026
- Germany (BfArM)
- No entry in the BfArM supply notices (checked 20 Nov 2026)
Registers: EU shortages · US shortages · German shortages · EMA approvals
Sodium chloride: supply and approvals
126 authorised products on the HPRA list contain Sodium chloride. Shortage records below are for the substance in the EU, US and German markets and may not affect this Irish product; for Irish supply, check with the HPRA or a pharmacist.
- EU shortage (EMA)
- No entry in the EMA shortage catalogue (checked 20 Nov 2026)
- US shortage (FDA)
- Sodium Acetate Injection: in shortage, updated 15 Nov 2026
- Germany (BfArM)
- No entry in the BfArM supply notices (checked 20 Nov 2026)
Registers: EU shortages · US shortages · German shortages · EMA approvals
About this licence
National authorisation (PA). A product authorisation granted by the HPRA for the Irish market. It has been authorised for 12 years (since 14 November 2014). The HPRA list marks it as marketed in Ireland.
Other medicines with Sodium citrate in Ireland
2 other products on the HPRA list contain Sodium citrate, from 2 licence holders; 2 of them are marked as marketed. Products with the same substance can differ in strength, form, other ingredients and what they are licensed for, so they are not automatically interchangeable.
| Medicine | Licence holder | Licence | Status |
|---|---|---|---|
| Casacol Expectorant SyrupMethoxyphenamine hydrochloride 20 mg/5 ml Guaiphenesin 100 mg/5 ml Sodium Citrate 200 mg/5 ml | Phoenix Labs Unlimited Company | National authorisation (PA) | Marketed |
| Microlax Rectal Solution Sodium Citrate 450 mg/5 ml Sodium Lauryl Sulphoacetate 45 mg/5 ml | JNTL Consumer Health I (Ireland) Limited | National authorisation (PA) | Marketed |
Other medicines with Sodium chloride in Ireland
121 other products on the HPRA list contain Sodium chloride, from 22 licence holders; 76 of them are marked as marketed. Products with the same substance can differ in strength, form, other ingredients and what they are licensed for, so they are not automatically interchangeable.
Other substances in ATC group B05ZB
The ATC system groups medicines by the part of the body they act on and their chemistry. On the HPRA list, 22 other active substances share the group B05ZB with this product:
Magnesium chloride hexahydrate (13) · Sodium hydrogen carbonate (13) · Potassium chloride (12) · Calcium chloride dihydrate (12) · Glucose monohydrate (6) · Lactic acid (5) · Glucose (as monohydrate) (4) · Calcium (4) · Magnesium (4) · Sodium (4) · Hydrogen carbonate (4) · Chloride (4) · Potassium (4) · Glucose (4) · Calcium chloride (3) · Magnesium chloride (3) · Sodium bicarbonate (3) · Lactate (3) · Glucose anhydrous (2) · Disodium phosphate dihydrate (2) · and 2 more
Numbers in brackets are products on the HPRA list. Sharing an ATC group does not mean two medicines can replace each other.
The licence holder
Vantive Belgium SRL holds 27 products on the HPRA list, with 43 different active substances; 14 of the products are marked as marketed.
This listing is regulatory information, not medical advice — consult the package leaflet, SPC, or a healthcare professional. For the authoritative record see the HPRA register.
How this page is built
The facts on this page are pulled directly from the HPRA's (Health Products Regulatory Authority) official open dataset — they are not written from memory, and nothing here is summarised or edited. Each field below names the dataset it came from, so you can check it yourself.
- HPRA Authorised Medicines List (open data) ↗ Licence number, holder, active substance(s), dosage form, route, ATC code(s), authorisation date and prescription status for this product
This page is built automatically: a daily sync job downloads HPRA's published XML export and copies the licence number, holder, active substance(s), dosage form, route, ATC code(s), authorisation date and prescription status directly into this page — no AI drafting and no per-product editorial pass. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The HPRA data on this page was last retrieved on 21 Nov 2026. How every register is built: methodology · fixes we have made: corrections log.